Psilocybin Shows Promise for Treating Obsessive Compulsive Disorder in Small Trial
University of Arizona researchers tested psychedelic therapy for OCD symptoms in 15-person clinical trial over four years.
6693 articles
University of Arizona researchers tested psychedelic therapy for OCD symptoms in 15-person clinical trial over four years.
University of Zurich researchers tested psilocybin against placebo in 37 alcohol-dependent patients using rigorous double-blind methodology.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
University researchers used psychedelic therapy and brain imaging to tackle cocaine addiction, revealing new neural pathways for recovery.
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
Small pilot study tests multicomponent behavioral program to reduce cognitive decline risk in underserved rural populations.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
French researchers followed 1,028 people with mild cognitive complaints to understand how dementia develops over time.
Nine-year study investigated whether solanezumab could slow memory decline in older adults with brain amyloid plaques.
Natural water therapy may offer safe relief from menopausal symptoms when hormone replacement isn't an option.
Singapore trial tests ancient herbal remedy against placebo for hormone-related dry eye in 150 postmenopausal women.
Small study tested optical breast scanner to identify women at risk for hormone therapy-induced breast cancer within months of treatment.